As part of the transaction, Gaymar has also acquired a new license agreement that gives the company exclusive worldwide rights to new gel technologies, offering promise for potential new medical mattress products.
The acquisition, consistent with Gaymar’s commitment to increase the production capacity for the gel components used in its Isoflex medical mattress, is expected to result in additional production capacity.
Frank Lumbar, CEO of Gaymar, said: “The assets of Sunshine Manufacturing clearly meet Gaymar’s criteria for strategic acquisitions. This acquisition will give Gaymar the ability to further support its Mission Statement to prevent or relieve pain and suffering and enhance the quality of life.”